Description
The Warren Family Research Center for Drug Discovery and Development is a collaborative program well aligned with the University’s overarching Catholic mission through its focus on the discovery and development of new therapeutic leads for the treatment of unmet clinical needs in a number of areas including cancer, infectious diseases, and a number of rare diseases. The Center brings together chemical and biological expertise and technologies through partnerships with researchers within the University’s biomedical research centers at the, including the Harper Cancer Institute, the Eck Institute for Global Health, the Center for Rare and Neglected Disease, and external partners, including regional universities and the Indiana CTSI, Eli Lilly, Inc. and other pharmaceutical companies as well as private foundations including the Ara Parseghian Medical Research Foundation and the Grace Science Foundation.
Donations are applied to...
During this exciting time, we have the unique opportunity to earn a portion of a $1 Million! Make a $10 gift on Notre Dame Day (April 24 – 25), and receive 5 votes to cast. The total number of votes we receive decides our percentage of the $1 Million. Please vote for us!
Personal Message
We are excited to announce our participation in Notre Dame Day, when the global Notre Dame family will come together to celebrate what each of us loves most about the University. This collaborative program is well aligned with the University’s overarching Catholic mission through its focus on the study and identification of new therapeutic leads for the treatment of unmet clinical needs including indications that afflict the most vulnerable among us and not being adequately addressed by large pharmaceutical companies.
Why are donations necessary?
All funds received from NDday will go directly to laboratory research being conducted in the Warren Center including the Chemical Synthesis and Drug Discovery Core Facility which supports translational biomedical research by providing expertise that enables the preparation of small molecules for use in hit verification, lead development, and midsize scale‐up. In addition, the core supports the preparation of biological probes (affinity, fluorescently tagged, etc.), active pharmaceutical agents as experimental controls, and small chemical libraries for structure-activity relationships and the optimization pharmacological properties. For use of our chemical synthesis services or to request a quote for inclusion in a grant submission. This shared user research core is also charged with organizational oversight of the products of past, current, and future chemical synthesis to create a university compound collection with currently 20,000 unique chemical entities. The establishment of appropriate intellectual property controls allows for participation of additional academic and industrial partners and the creation of a regional drug discovery consortium through the Indiana Clinical and Translational Science Institute (Indiana CTSI).